Gotham Asset Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,717
Closed -$310K 1407
2023
Q4
$310K Sell
10,717
-3,553
-25% -$95.1K 0.01% 1128
2023
Q3
$382K Sell
14,270
-17,575
-55% -$600K 0.01% 1042
2023
Q2
$1.18M Sell
31,845
-661
-2% -$23K 0.03% 719
2023
Q1
$1.01M Sell
32,506
-15,308
-32% -$493K 0.02% 740
2022
Q4
$1.42M Sell
47,814
-2,563
-5% -$91.7K 0.04% 551
2022
Q3
$1.92M Sell
50,377
-13,224
-21% -$663K 0.06% 409
2022
Q2
$3.47M Buy
63,601
+5,217
+9% +$287K 0.11% 220
2022
Q1
$3.64M Buy
58,384
+22,664
+63% +$1.49M 0.11% 224
2021
Q4
$3.59M Buy
35,720
+10,845
+44% +$953K 0.12% 221
2021
Q3
$2.24M Sell
24,875
-16,688
-40% -$1.52M 0.09% 278
2021
Q2
$3.83M Buy
41,563
+27,138
+188% +$2.17M 0.16% 183
2021
Q1
$1.39M Buy
+14,425
New +$1.49M 0.06% 376

Other funds holding FLGT

Gotham Asset Management's FLGT Position: Q1 2024 in Review

Gotham Asset Management sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 10,717 shares — an estimated $310K sold.

Gotham Asset Management first reported a position in FLGT in Q1 2021 and held it in 12 quarters. The position peaked at $3.83M in Q2 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Gotham Asset Management reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Gotham Asset Management sold 10,717 Fulgent Genetics shares in Q1 2024, an estimated $310K.
  • Gotham Asset Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 12 quarters.
  • Gotham Asset Management's Fulgent Genetics position peaked at $3.83M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Gotham Asset Management's 13F filing for Q1 2024, filed 15 May 2024.